论文部分内容阅读
目的探讨低分子肝素加早期康复综合治疗急性脑梗塞的临床疗效,为今后临床治疗急性脑梗塞提供科学有效的治疗方案。方法选择从2006年1月至2013年4月在内科住院治疗的100例本市急性脑梗塞患者,按照随机原则平均分为实验组和对照组,对照组患者采用甘露醇、低分子右旋糖苷及低分子肝素5000U皮下注射,实验组患者在此治疗基础上同时进行早期康复治疗,对比两组患者治疗效果。结果实验组治愈25例,总有效率为96%;对照组治愈12例,总有效率为92%,两组比较显效率差异明显。结论对急性脑梗塞患者在运用低分子肝素治疗的基础上加用早期康复综合治疗可显著提高显效率,从而提高患者生活质量,帮助患者早日回归社会。
Objective To investigate the clinical efficacy of low molecular weight heparin combined with early rehabilitation in the treatment of acute cerebral infarction and to provide a scientific and effective treatment plan for clinical treatment of acute cerebral infarction. Methods From January 2006 to April 2013, 100 patients with acute cerebral infarction in our hospital were randomly divided into experimental group and control group according to the principle of randomization. Patients in the control group were treated with mannitol, low molecular weight dextran And low molecular weight heparin 5000U subcutaneous injection, the experimental group patients on the basis of this treatment at the same time early rehabilitation treatment, the treatment effect of two groups were compared. Results In the experimental group, 25 cases were cured and the total effective rate was 96%. In the control group, 12 cases were cured and the total effective rate was 92%. There was significant difference between the two groups. Conclusions The treatment of acute cerebral infarction with low molecular weight heparin treatment based on the combination of early rehabilitation can significantly improve the markedly effective rate, thereby enhancing the quality of life of patients and help patients return to society as soon as possible.